Associated Papers
Established and Emerging Nucleic Acid Therapies for Familial Hypercholesterolemia.
Damase TR et al.
Circulation, 2024
Pharmacotherapy in familial hypercholesterolemia - Current state and emerging paradigms.
Kallapur A et al.
Trends in Cardiovascular Medicine, 2023
Low-density lipoprotein receptor genotypes modify the sera metabolome of patients with homozygous familial hypercholesterolemia.
Du Z et al.
Iscience, 2022
36325061 (PubMed )
Supplement: mmc2.xlsx › Table_S1
Limited-Variant Screening vs Comprehensive Genetic Testing for Familial Hypercholesterolemia Diagnosis.
Sturm AC et al.
Jama Cardiology, 2021
34037665 (PubMed )
Supplement: jamacardiol-e211301-s001.pdf
Homozygous familial hypercholesterolemia: what treatments are on the horizon?
Bajaj A et al.
Current Opinion in Lipidology, 2020
In Vivo AAV-CRISPR/Cas9-Mediated Gene Editing Ameliorates Atherosclerosis in Familial Hypercholesterolemia.
Zhao H et al.
Circulation, 2020
Select a paper to view details